Epilepsy pathophysiology

Jump to navigation Jump to search
https://https://www.youtube.com/watch?v=ONvvTbKR_UA%7C350}}

Epilepsy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Epilepsy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

EEG

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Epilepsy pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Epilepsy pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Epilepsy pathophysiology

CDC on Epilepsy pathophysiology

Epilepsy pathophysiology in the news

Blogs on Epilepsy pathophysiology

Directions to Hospitals Treating Epilepsy

Risk calculators and risk factors for Epilepsy pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

It is understood that epileptic seizure is the result of uncontrolled unusual synchronized, localized or widely distributed neuronal electrical discharges. The underlying event in all types of seizures is the paroxysmal depolarization shift (PDS) which also causes the EEG changes. In a normal circumstance we have a refractory period after every action potential, but in PDS, the absence of refractory period causes a prolonged membrane depolarization. In order to cause a seizure, so many PDSs most happen in the same time. Any alternation in a synaptic characteristics such as amount of neurotransmitters, function of inhibitory neurons, function of excitatory neurons, synaptic structure and ion channels involved in neurotransmitter release and conduction of action potential can prone a person to epilepsy. In focal epilepsy, epileptiform activity starts in a specific area of brain. It can further spread and cause secondary generalized seizure. In generalized epilepsy seizures occur in both cerebral hemispheres simultaneously or spread so fast from one to another that in EEG, we can see bilateral epileptiform activity from the start.

Pathophysiology

Physiology

By Original by en:User:Chris 73, updated by en:User:Diberri, converted to SVG by tiZom - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=2241513

Pathogenesis

Genetics

Gross Pathology

Microscopic Pathology

References

  1. Pollard, Thomas (2017). Cell biology. Philadelphia, PA: Elsevier. ISBN 9780323341264.
  2. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J (April 2005). "Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)". Epilepsia. 46 (4): 470–2. doi:10.1111/j.0013-9580.2005.66104.x. PMID 15816939.
  3. MATSUMOTO H, AJMONEMARSAN C (April 1964). "CELLULAR MECHANISMS IN EXPERIMENTAL EPILEPTIC SEIZURES". Science. 144 (3615): 193–4. PMID 14107481.
  4. Bragin A, Engel J, Wilson CL, Fried I, Mathern GW (February 1999). "Hippocampal and entorhinal cortex high-frequency oscillations (100--500 Hz) in human epileptic brain and in kainic acid--treated rats with chronic seizures". Epilepsia. 40 (2): 127–37. PMID 9952257.
  5. Chang BS, Lowenstein DH (September 2003). "Epilepsy". N. Engl. J. Med. 349 (13): 1257–66. doi:10.1056/NEJMra022308. PMID 14507951.
  6. Samuels, Martin (2017). Samuels's Manual of neurologic therapeutics. Philadelphia: Wolters Kluwer Health. ISBN 9781496360311.
  7. Mattle, Heinrich (2017). Fundamentals of neurology : an illustrated guide. Stuttgart New York: Thieme. ISBN 9783131364524.
  8. 8.0 8.1 Samuels, Martin (2017). Samuels's Manual of neurologic therapeutics. Philadelphia: Wolters Kluwer Health. ISBN 9781496360311.
  9. Miriam H. Meisler and Jennifer A. Kearney (2005). "Sodium channel mutations in epilepsy and other neurological disorders". Journal of Clinical Investigation. 115 (8): 2010–2017. PMID 16075041 doi:10.1172/JCI25466.
  10. GOWERS, FirstName (2016). EPILEPSY AND OTHER CHRONIC CONVULSIVE DISEASES : their causes, symptoms, and treatment (classic... reprint. S.l: FORGOTTEN BOOKS. ISBN 1334720053.
  11. Blümcke I, Thom M, Aronica E, Armstrong DD, Bartolomei F, Bernasconi A, Bernasconi N, Bien CG, Cendes F, Coras R, Cross JH, Jacques TS, Kahane P, Mathern GW, Miyata H, Moshé SL, Oz B, Özkara Ç, Perucca E, Sisodiya S, Wiebe S, Spreafico R (July 2013). "International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods". Epilepsia. 54 (7): 1315–29. doi:10.1111/epi.12220. PMID 23692496.

Template:WH Template:WS